Neoplasms
Showing 1 - 25 of 928
Myeloproliferative Disorders, Essential Thrombocythemia, Tumors Trial (JNJ-88549968)
Not yet recruiting
- Myeloproliferative Disorders
- +3 more
- (no location specified)
Nov 21, 2023
Tumors Trial in Strasbourg (Advance Care Planning Intervention)
Not yet recruiting
- Neoplasms
- Advance Care Planning Intervention
-
Strasbourg, FranceInstitut de cancérologie Strasbourg Europe
Nov 20, 2023
Anatomical-Clinical Base of Adenocarcinoma Pancreatic
Recruiting
- Adenocarcinoma
- +2 more
- collection of biological samples
-
Bordeaux, France
- +7 more
Nov 20, 2023
Tumors, Kidney Tumors, Urologic Tumors Trial in Nanjing (Toripalimab, Axitinib, Lenvatinib)
Recruiting
- Neoplasms
- +12 more
- Toripalimab
- +3 more
-
Nanjing, Jiangsu, ChinaJinling Hospital, Affiliated Hospital of Medical School, Nanjing
Oct 28, 2023
Breast Cancer, Breast Tumors, Breast Cancer Female Trial in United States (contrast-enhanced mammography)
Recruiting
- Breast Cancer
- +3 more
- contrast-enhanced mammography
-
Bethel Park, Pennsylvania
- +4 more
Oct 23, 2023
Tumors Trial in Chengdu
Recruiting
- Neoplasms
-
Chengdu, Sichuan, ChinaDepartments of Nuclear Medicine, Sichuan Provincial People's Hos
Oct 16, 2023
Tumors Trial in Nice (Self-questionnaire)
Recruiting
- Neoplasms
- Self-questionnaire
-
Nice, FranceCentre Antoine lacassagne
Sep 21, 2023
Tumors Trial in Singapore (ENABLE-SG model, Wait-list control)
Not yet recruiting
- Neoplasms
- ENABLE-SG model
- Wait-list control
-
Singapore, SingaporeNational Cancer Centre Singapore
Sep 12, 2023
Tumors, Advance Care Planning Trial (Culturally Tailored Digital Resilience-Building)
Not yet recruiting
- Neoplasms
- Advance Care Planning
- Culturally Tailored Digital Resilience-Building
- (no location specified)
Sep 6, 2023
Tumors, Prostate Cancer, Exercise Trial in Tucson (Exercising together)
Not yet recruiting
- Neoplasms
- +3 more
- Exercising together
-
Tucson, ArizonaUniversity of Arizona Cancer Center
Aug 30, 2023
Tumors, Cancer, Mental Health Disorder Trial in Taipei (Forest Therapy)
Completed
- Neoplasms
- +3 more
- Forest Therapy
-
Taipei, TaiwanTaipei city hospital
Aug 19, 2023
Noninvasive Internal Jugular Venous Oximetry
Recruiting
- Neoplasms
-
Taipei, TaiwanNational Taiwan University Hospital
Aug 17, 2023
Cardiotoxicity, Tumors, Chemo Effect Trial in São Paulo (Spironolactone, Placebo)
Not yet recruiting
- Cardiotoxicity
- +3 more
- Spironolactone
- Placebo
-
São Paulo, BrazilInstituto do Coração
Aug 16, 2023
Lung Cancer, Multiple Pulmonary Nodules, Lung Tumors Trial in Orlando, Rochester, Pinehurst (Ion Endoluminal System)
Not yet recruiting
- Lung Cancer
- +8 more
- Ion Endoluminal System
-
Orlando, Florida
- +2 more
Aug 16, 2023
Tumors, Lung Cancer, Physical Inactivity Trial in Hong Kong (Regular message delivery, Chat-type support message delivery)
Not yet recruiting
- Neoplasms
- +3 more
- Regular message delivery
- Chat-type support message delivery
-
Hong Kong, Hong KongSchool of Nursing, The University of Hong Kong
Aug 15, 2023
Tumors, Child, Adolescent Trial in Leiden (Ramucirumab, Cyclophosphamide, Vinorelbine)
Recruiting
- Neoplasms
- +2 more
- Ramucirumab
- +7 more
-
Leiden, NetherlandsLeids Universitair Medisch Centrum
Aug 14, 2023
Tumors Trial in Worldwide (Letetresgene autoleucel)
Active, not recruiting
- Neoplasms
- Letetresgene autoleucel
-
Pittsburgh, Pennsylvania
- +5 more
Aug 7, 2023
Tumors Trial (Nordic Walking, Aquatic Exercise, Functional Exercise Training)
Not yet recruiting
- Neoplasms
- Nordic Walking
- +2 more
- (no location specified)
Jul 28, 2023
Tumors, Carcinoma, Squamous, Antineoplastic Agents Trial (Nivolumab Injection [Opdivo])
Not yet recruiting
- Neoplasms
- +2 more
- Nivolumab Injection [Opdivo]
- (no location specified)
Jul 19, 2023
Tumors Trial in Hong Kong (A nurse-led symptom distress screening program)
Not yet recruiting
- Neoplasms
- A nurse-led symptom distress screening program
-
Hong Kong, Hong Kong
- +9 more
Jul 17, 2023
Tumors, Prostatic Tumors, Castration-Resistant, Stomach Tumors Trial in United Kingdom (HTL0039732 Capsules, HTL0039732 Capsules
Recruiting
- Neoplasms
- +13 more
- HTL0039732 Capsules
- HTL0039732 Capsules and atezolizumab infusion
-
Cambridge, United Kingdom
- +4 more
Jul 5, 2023